Brett S. Spector
Director/Miembro de la Junta en Fesariustherapeutics, Inc. .
Perfil
Brett S.
Spector is currently a Director at Fesariustherapeutics, Inc. He was previously the President at SuttonBrook Capital Management LP from 2009 to 2012.
Cargos activos de Brett S. Spector
Empresas | Cargo | Inicio |
---|---|---|
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Brett S. Spector.
Empresas | Cargo | Fin |
---|---|---|
SuttonBrook Capital Management LP
SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City. | Director Financiero/CFO | 01/04/2012 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
SuttonBrook Capital Management LP
SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Brett S. Spector